Position in BIIB
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$139,912,689
+$32,398,991 QoQ
Shares Held
763,174
+24.9% QoQ
Ownership
0.517%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 54.14571251117045.ToString("F0")%
Shared 0.ToString("F0")%
None 45.85428748882955.ToString("F0")%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Robeco Institutional Asset Management B.V. holds $3,535,801,813 across 9 Drug Manufacturers - General names. BIIB ranks #9 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
3,250,326 | $706,913,401 | |
| 2 | LLY |
ELI LILLY & Co
|
653,146 | $600,744,096 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
3,354,394 | $467,501,891 | |
| 4 | JNJ |
Johnson & Johnson
|
1,721,249 | $420,742,105 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
6,733,740 | $408,401,331 | |
| 6 | PFE |
Pfizer Inc
|
11,138,434 | $312,767,226 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,322,293 | $279,348,624 | |
| 8 | AMGN |
Amgen Inc
|
566,919 | $199,470,450 |
All Filings in BIIB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $139,912,689 | 763,174 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $107,513,698 | 610,908 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $94,001,244 | 671,054 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $56,359,391 | 448,757 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $62,060,908 | 453,529 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $62,433,565 | 408,276 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $53,249,398 | 274,708 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $49,826,695 | 214,937 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $49,921,795 | 231,516 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $75,959,345 | 293,540 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $87,848,588 | 341,810 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $97,765,362 | 343,217 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $100,493,109 | 361,447 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $86,719,436 | 313,157 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $82,186,872 | 307,816 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $37,017,353 | 181,511 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $37,401,717 | 177,596 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $45,888,298 | 191,265 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $48,719,841 | 172,161 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $56,942,370 | 164,445 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $77,096,022 | 275,589 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $79,456,825 | 324,499 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $159,730,562 | 563,066 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $107,731,147 | 402,658 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $82,084,158 | 259,448 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||